AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $135,000 | -54.2% | 111,620 | -34.1% | 0.01% | -55.2% |
| Q2 2015 | $295,000 | +360.9% | 169,279 | +283.2% | 0.03% | +383.3% |
| Q1 2015 | $64,000 | -70.9% | 44,177 | -77.8% | 0.01% | -68.4% |
| Q3 2014 | $220,000 | -42.9% | 198,571 | -5.6% | 0.02% | -36.7% |
| Q2 2014 | $385,000 | +45.8% | 210,369 | +19.1% | 0.03% | +76.5% |
| Q1 2014 | $264,000 | -48.8% | 176,633 | -37.3% | 0.02% | -29.2% |
| Q4 2013 | $516,000 | -70.0% | 281,744 | -66.2% | 0.02% | -69.2% |
| Q3 2013 | $1,718,000 | +107.0% | 833,762 | +151.2% | 0.08% | +122.9% |
| Q2 2013 | $830,000 | – | 331,912 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |